These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 7720242)

  • 1. Progastrin-Releasing Peptide As a Diagnostic Biomarker of Pulmonary and Non-Pulmonary Neuroendocrine Neoplasms.
    La Salvia A; Fanciulli G
    Endocr Res; 2024 Jul; ():1-8. PubMed ID: 39041209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference intervals for serum progastrin-releasing peptide in healthy Chinese adults with electrochemiluminescence immunoassay.
    Yang Y; Zheng T; Jiang H; Tang A; Xiang Z
    Int J Biol Markers; 2018 May; ():1724600818776828. PubMed ID: 29888676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-gastrin-releasing peptide as a marker for the Ewing sarcoma family of tumors.
    Honda Y; Katagiri H; Takahashi M; Murata H; Wasa J; Hosaka S; Ishida Y; Ito I; Muramatsu K; Mochizuki T; Matsuyama Y; Yamaguchi K
    Int J Clin Oncol; 2019 Nov; 24(11):1468-1478. PubMed ID: 31264078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China.
    Wu XY; Hu YB; Li HJ; Wan B; Zhang CX; Zhang B; Hu H; Zhang Q; Lv TF; Zhan P; Song Y
    J Cell Mol Med; 2018 Sep; 22(9):4328-4334. PubMed ID: 29989303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.
    Wojcik E; Kulpa JK
    Lung Cancer (Auckl); 2017; 8():231-240. PubMed ID: 29238236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer.
    Lv ShP; Wang Y; Huang L; Wang F; Zhou JG; Ma H
    Asian Pac J Cancer Prev; 2017 Feb; 18(2):391-397. PubMed ID: 28345820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated Protein Biomarker Analysis: on-line extraction of clinical samples by Molecularly Imprinted Polymers.
    Rossetti C; Świtnicka-Plak MA; Grønhaug Halvorsen T; Cormack PA; Sellergren B; Reubsaet L
    Sci Rep; 2017 Mar; 7():44298. PubMed ID: 28303910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer.
    Jiang Y; Wang C; Lv B; Ma G; Wang L
    Int J Clin Exp Med; 2014; 7(12):5568-72. PubMed ID: 25664073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and clinical validity of two immunoassays for ProGRP.
    Nordlund MS; Stieber P; Brustugun OT; Warren DJ; Paus E
    Tumour Biol; 2012 Aug; 33(4):1105-13. PubMed ID: 22399443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma proGRP concentration is sensitive and specific for discriminating small cell lung cancer from nonmalignant conditions or non-small cell lung cancer.
    Kim HR; Oh IJ; Shin MG; Park JS; Choi HJ; Ban HJ; Kim KS; Kim YC; Shin JH; Ryang DW; Suh SP
    J Korean Med Sci; 2011 May; 26(5):625-30. PubMed ID: 21532852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of small cell lung cancer.
    Taneja TK; Sharma SK
    World J Surg Oncol; 2004 May; 2():10. PubMed ID: 15128454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase.
    Takada M; Kusunoki Y; Masuda N; Matui K; Yana T; Ushijima S; Iida K; Tamura K; Komiya T; Kawase I; Kikui N; Morino H; Fukuoka M
    Br J Cancer; 1996 May; 73(10):1227-32. PubMed ID: 8630283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme immunoassay of immunoreactive progastrin-releasing peptide(31-98) as tumor marker for small-cell lung carcinoma: development and evaluation.
    Aoyagi K; Miyake Y; Urakami K; Kashiwakuma T; Hasegawa A; Kodama T; Yamaguchi K
    Clin Chem; 1995 Apr; 41(4):537-43. PubMed ID: 7720242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
    Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
    Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma.
    Miyake Y; Kodama T; Yamaguchi K
    Cancer Res; 1994 Apr; 54(8):2136-40. PubMed ID: 8174119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ProGRP: a new biomarker for small cell lung cancer.
    Molina R; Filella X; Augé JM
    Clin Biochem; 2004 Jul; 37(7):505-11. PubMed ID: 15234231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pro gastrin-releasing peptide (ProGRP)].
    Ishikawa H; Saito T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():759-61. PubMed ID: 16149633
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.